Tech Company Financing Transactions
Artelon Funding Round
On 5/24/2023, Artelon announced $20 million in Series B funding from Vensana Capital.
Transaction Overview
Company Name
Announced On
5/24/2023
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Vensana Capital (Lead Investor) (Greg Banker)
Proceeds Purpose
The financing will fund commercial growth, clinical research, and expansion of Artelon's product line for surgical treatment of ankles and other joints.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2150 NW Parkway SE G
Marietta, GA 30067
USA
Marietta, GA 30067
USA
Phone
Website
Email Address
Overview
The original vision for Artelon was cast by world renown orthopedic surgeon Lars Peterson, MD/PhD. His experience clinically investigating multiple synthetic tendon and ligament devices that failed highlighted key design features necessary for a synthetic material to demonstrate real-world success in connective tissue reconstruction. Working with an elite team of chemists and textile engineers, Dr. Peterson's vision came to fruition in the form of Artelon's Dynamic Matrix. Since it's inception, this technology has delivered on its promise of enhanced biological and mechanical soft tissue reconstruction with over 60,000 implantations worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aaron Smith
Chief Financial Officer
Jeff Byrne
Founder
Lars Peterson
Browse more venture capital transactions:
Prev: 5/24/2023: Sekoia.io venture capital transaction
Next: 5/24/2023: InProTher venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs